JA - Nebraska Wu Lab Transgenic Mice - Signed.pdf

Justification and Approval for Sole Source (J&A) (Template)

Completion Instructions: HHS has established a standard template for preparation of a Justification and Approval for Sole Source (J&A) for non-Federal Supply Schedule acquisitions exceeding the simplified acquisition threshold. Operating Divisions (OPDIVs) shall prepare the template in accordance with these completion instructions.

(NOTE: The Project Officer (PO) has responsibility for completing all of the information items included in the template, with any necessary assistance from the cognizant Contracting Officer (CO) and Contract Specialist (CS) -- especially for items 3.(b), 4., 6., 7., 8. and 10. listed below.

The instructions for preparing a J&A are specified in “red” and should be deleted prior to processing the document for review and approval. Also, do not include the completion instructions in the completed document.

A completed J & A must contain all of the applicable bolded headings in the order specified. Place the required information directly next to, or under, the applicable heading. If a heading does not apply to a specific J & A, indicate “not applicable” (N/A) next to it. Reference and attach any additional information necessary to support the J & A.

Justification and Approval for Sole Source

“Source Selection Information – see FAR 2.101 and 3.104”

1. Identification of the agency and contracting activity.

a. Federal agency and contracting activity. HHS. NIH

b. Sponsoring organization. NIDCD: Laboratory of Molecular Biology

c. Project Officer information

• Project Officer name. Doris K. Wu

• Mailing address. 35A Convent Dr. #1D824, Bethesda, MD

20892

• E-mail address. wud@nidcd.nih.gov

• Telephone number. 301-402-4214

2. Nature and/or description of the action being approved.

mailto:wud@nidcd.nih.gov

a. Acquisition purpose and objectives. Transgenic mouse with a cre attached to two different genes to study development of the inner ear, per our mission.

b. Project background. We use mice of various genetic backgrounds in order to study how individual genes affect the development of the inner ear to determine how each gene functions in a normally function system.

3. Description of the supplies or services required to meet the agency’s needs (including the estimated value).

a. Project title. Generation of transgenic mice

b. Project description. Create transgenic mice to study inner ear development

Provide the following information:

• Requirement type. Check the appropriate box:

X Research & development (R&D) X R & D support services Support services (non-R&D) Supplies/equipment Information technology (IT) Construction Architect-engineer (A & E) services Design-build Other (specify):

• Type of action. Check the appropriate box:

New requirement Follow-on X Other (specify): Continuing research

• Proposed contract/order type. Check all that apply:

X Firm-fixed-price Other fixed-price (specify, e.g., fixed-price award-fee, fixed-price incentive-fee):

Cost-plus-fixed-fee Other cost reimbursement (specify, e.g., cost-plus-award-fee, cost-plus-incentive-fee):

Time and materials Indefinite delivery (specify whether indefinite quantity, definite quantity, or requirements):

Other (specify):

Completion Form Term form

• Acquisition identification number. POTS# 20-002707

• c. Total estimated dollar value and performance/delivery period. $39412.00 upon project creation (12-18 months)

4. Identification of the statutory authority permitting other than full and open competition. Check the applicable block below based on the acquisition circumstance.

X This acquisition is conducted under the authority of 41 United

States Code (U.S.C.) 253(c)( ) as set forth in Federal Acquisition Regulation (FAR) 6.302- 1 .

This acquisition is conducted under the authority of section 4202 of the Clinger-Cohen Act of 1996.

This acquisition is conducted under the authority of the Services

Acquisition Reform Act of 2003 (41 U.S.C. 428a).

5. Demonstration that the proposed contractor(s) unique qualifications or the nature of the acquisition requires use of the authority cited.

Provide the following information, as applicable:

a. Name and address of the proposed contractor(s). University of Nebraska Medical Center, department of Pharmacology and Experimental Neuroscience, 985880 Nebraska Mendical Center, Omaha, NE 68198

b. Nature of the acquisition and proposed unique qualifications of the contractor(s). They are the only known entity that uses EASI-CRISPR.

6. Description of the efforts made to ensure that offers are solicited from as many potential sources as practicable. Indicate whether a FedBizOpps notice was or will be publicized as required by FAR Subpart 5.2 and, if not, which exception under FAR 5.202 applies. I do not know what this is.

7. Determination by the Contracting Officer that the anticipated cost/price to the Government will be fair and reasonable. The use of EASI_CRISPR makes the project more precise and accurate minimizing the likelihood of cost overruns

8. Description of the market research conducted (see FAR Part 10) and the results, or a statement of the reasons market research was not conducted.

We have used this group before and find them to be fair priced and accurate

9. Any other facts supporting the use of other than full and open competition.

N/A

10. Listing of sources, if any, that expressed, in writing, an interest in the acquisition. None requested

11. Statement of the actions, if any, the agency may take to remove or overcome any barriers to competition before any subsequent acquisition for the required supplies or services. There are no current future plans, but the likelihood that we will want to acquire more transgenic mice as more is discovered of the genetics of mice and humans is extremely high.

12. Program office certification. The program officials cited shall complete the information required below and sign the certification in the blocks provided.

This is to certify that the portions of this justification that have been developed by the undersigned program office personnel, including supporting information and/or data verifying the Government’s minimum needs, schedule requirements and other rationale for other than full and open competition, are accurate and complete.

Official Name & Title Signature Date

Project Officer Michael Mulheisen

7/30/2020

Project Officer’s

Immediate Supervisor

Doris K. Wu Type text here

7/30/2020

Head of the Sponsoring

Thomas Friedman Digitally s for Lynne E. Penn -S -S Date: 2020 ned by Lynne E. Penn

.08.04 09:59:11 -04'00'

13. Contracting Officer certification.

This is to certify that the justification for the proposed acquisition has been reviewed and that to the best of my knowledge and belief the information and/or data provided to support the rationale and recommendation for approval is accurate and complete.

Official Name & Title Signature Date

Contracting Officer